Patents
Patents for C07D 277 - Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings (33,621)
09/2010
09/16/2010US20100234612 Intermediate of 6-substituted-1-methyl-1-H-benzimidazole derivative and method for producing same
09/16/2010US20100234611 Fluorination Process of Anilide Derivatives and Benzothiazole Fluorinate Derivatives as in VIVO Imaging Agents
09/16/2010US20100234398 Insecticidal n-substituted (heteroaryl)alkyl sulfilimines
09/16/2010US20100234350 Platelet adp receptor inhibitors
09/16/2010US20100234345 Novel compounds as cannabinoid receptor ligands
09/15/2010EP2228364A1 Acylsulfonamides as inhibitors of steroid sulfatase
09/15/2010EP2227458A2 2-(benzyl- and 1h-pyrazol-4-ylmethyl)sulfinyl-thiazol-derivatives as herbicides and plant growth regulators
09/15/2010EP2227453A2 Heteroaryl amides useful as inhibitors of voltage-gated sodium channels
09/15/2010CN101835766A New compounds as adenosine a1 receptor antagonists
09/15/2010CN101835765A Alkylsulfonyl-substituted thiazolide compounds
09/15/2010CN101835764A Azolecarboxamide compound or salt thereof
09/15/2010CN101835751A Cyclohexeneamide derivatives and their use as TRPV1 antagonist
09/15/2010CN101830864A Improvement of synthesis method of 6-hydroxy-2-(4'-aminophenyl) benzothiazole
09/15/2010CN101830863A Method and intermediate compound for preparing ligand of PPAR (Peroxisome Proliferator-Activated Receptor) delta
09/15/2010CN101830855A Substituted nitrogen-containing benzoheterocycle compounds and preparation method and application thereof
09/15/2010CN101137363B [4-(heteroaryl)piperazin-1-yl]-(2,5-substituted -phenyl)methanone derivatives as glycine transporter 1 (Glyt-1) inhibitors for the treatment of neurological and neuropsychiatric disorders
09/15/2010CN101012207B Fluorescent probe for detecting ultra-oxygen anion free radical, synthesis method and use
09/14/2010US7795471 Triethylamine was added dropwise to a solution of 2-methylpropane-2-sulfinyl chloride and methyl trans-4-amino-1-cyclohexane carboxylate p-toluenesulfonate in tetrahydrofuran solvent to obtain Methyl trans-4-(2-methylpropane-2-sulfonylamino)cyclohexanecarboxylate; hydrolysis; oxidation; intermediates
09/14/2010US7795444 4-[2-(S)-(4-Ethylthiazol-2-yl)-2-(2-phenylacetylamido)ethyl]phenyl}sulfamic acid; anticarcinogenic, antitumor, antidiabrtic agent; angiogenesis inhibitor; sarcoid, syphilis, Paget's disease, vein occlusion, artery occlusion, carotid obstructive disease, chronic uveitis/vitritis
09/14/2010US7795442 halogenation or sulfonylation,coupling
09/14/2010US7795304 such as S)-[6-Hydroxycarbamoyl-1-(4-phenyl-thiazol-2-ylcarbamoyl)-hexyl]-carbamic acid benzyl ester, useful in the prevention and/or treatment cancer, restenosis, autoimmune diseases, allergies, inflammatory diseases, nervous system disorders such as neurodegenerative diseases
09/14/2010US7795290 enzyme synthetase, ligase and/or kinase inhibitors such as N-(3-(diethylamino)propyl)-N-(4-(2,5-dimethoxyphenyl)thiazol-2-yl)benzamide, used for treating Alzheimer's disease, strokes, diabetes, obesity, inflammation, cancer and rheumatoid arthritis
09/14/2010US7795289 Use of acylaminothiazole derivatives as therapeutic agents
09/14/2010US7795288 Thiazole and pyrazole derivatives as Flt-3 kinase inhibitors
09/14/2010US7795287 Therapeutic substituted hydantoins and related compounds
09/14/2010US7795284 cdc25 tyrosine phosphatase inhibitors such as 5-{[2-(dimethylamino)ethyl]amino}-2-(morpholin-4-ylcarbonyl)-1,3-benzothiazole-4,7-dione, used as anticarcinogenic agents
09/14/2010CA2422805C Retinoids for the treatment of emphysema
09/14/2010CA2394276C Serine protease inhibitors
09/10/2010WO2010100144A1 Fused bicyclic compounds as inhibitors for pi3 kinase
09/09/2010US20100228015 Prodrug derivatives of acids using alcohols with homotopic hydroxy groups and methods for their preparation and use
09/09/2010US20100228008 Dyes linked to target molecules, oligonucleotides or polynucleotides comprising dye molecules, composite dyes and other compositions useful for detecting or quantifying desirable target molecules
09/09/2010US20100227892 Compounds, Compositions and Methods for Treatment and Prevention of Orthopoxvirus Infections and Associated Diseases
09/09/2010US20100226969 Compounds for inhibiting protein aggregation, and methods for making and using them
09/09/2010US20100226882 Linked diimidazole antivirals
09/08/2010EP2226321A2 Process for producing thiazolidinediones and intermediates thereof
09/08/2010EP2226318A2 Dye-Azide compounds for dual photherapy
09/08/2010EP2225218A1 Thiazolyloxyphenylamidines or thiadiazolyloxyphenylamidines and their use as fungicides
09/08/2010EP2225216A1 Substituted benzoazole pde4 inhibitors for treating pulmonary and cardiovascular disorders
09/08/2010EP2225215A1 Substituted benzoazole pde4 inhibitors for treating inflammatory, cardiovascular and cns disorders
09/08/2010EP1751125B1 Ritonavir analogous compound useful as retroviral protease inhibitor, preparation of the ritonavir analogous compound and pharmaceutical composition for the ritonavir analogous compound.
09/08/2010CN101827832A Acetamide derivatives as glucokinase activators, their process and medicinal applications
09/08/2010CN101827827A 6-aryl/heteroalkyloxy benzothiazole and benzimidazole derivatives, method for preparing same, application thereof as drugs, pharmaceutical compositions and novel use in particular as C-MET inhibitors
09/08/2010CN101827817A Saturated and insaturated bi- or tricyclic aryloxyacetamide derivatives and their use as fungicides
09/08/2010CN101824007A New crystal form M of Febuxostat and preparation method thereof
09/08/2010CN101824006A New crystal form P of Febuxostat and preparation method thereof
09/08/2010CN101824005A New crystal form Q of Febuxostat and preparation method thereof
09/08/2010CN101824004A Synthesization technique for ceftibuten side chain
09/08/2010CN101391988B Method for preparing 2-(4-hydroxyl phenyl)-4-methyl-1,3-thiazole-5-carboxylic acid ethyl ester by one pot method
09/08/2010CN101386605B Febustat novel crystal and preparation method thereof
09/08/2010CN101343257B Process for preparing rubber accelerator TBBS
09/08/2010CN101037420B New crystal type of netoglitazone and preparation method thereof
09/07/2010US7790758 glutamate receptors agonists; especially to treat psychotic conditions, including schizophrenia and enhancement of cognition; N-{-2-[4-(6-fluoro-3-pyridinyl)phenyl]cyclopropyl}-2-propanesulfonamide; stereoselectively epoxidising a suitable styrene; coupling with boronic acid derivatives
09/07/2010US7790725 Thiazolidine derivatives and medicinal use thereof
09/07/2010CA2179935C Novel dipeptide compound or pharmaceutically acceptable salt thereof and medical use thereof
09/02/2010WO2010098600A2 Substituted azole derivatives, pharmaceutical composition containing the derivatives, and method for treating parkinson's disease using the same
09/02/2010WO2010098428A1 Process for producing phenyl-substituted heterocyclic derivative through coupling using transition metal catalyst
09/02/2010WO2010098396A1 Process for producing phenyl-substituted heterocyclic derivative
09/02/2010US20100222595 Intermediates for the preparation of pramipexole
09/02/2010US20100222580 Process For The Preparation Of Onium Alkylsulfates Having A Low Halide Content
09/02/2010US20100222399 Thiazolidinedione Analogues For The Treatment Of Hypertension
09/02/2010US20100222392 Insecticidal compounds
09/02/2010US20100222361 2-acylaminothiazole derivative or salt thereof
09/02/2010US20100222352 Compounds and Methods for the Treatment of Viruses and Cancer
09/02/2010US20100222329 2-acylaminothiazole derivative or salt thereof
09/02/2010US20100222217 Fungicidal N-[2-(Haloalkoxy)Phenyl]Heteroarylcarboxamides
09/02/2010CA2752485A1 Process for producing phenyl-substituted heterocyclic derivative through coupling using transition metal catalyst
09/02/2010CA2751343A1 Substituted azole derivatives, pharmaceutical composition containing the derivatives, and method for treating parkinson's disease using the same
09/01/2010EP2223918A1 Conjugated compound, nitrogenated condensed-ring compound, nitrogenated condensed-ring polymer, organic thin film, and organic thin film element
09/01/2010EP2222655A1 N-cycl0alkylmethyl-2-amin0thiaz0le-5-carb0xamides for use in plant disease control
09/01/2010EP2222272A1 Respiratory disease treatment
09/01/2010EP2222165A1 Novel compounds as cannabinoid receptor ligands and uses thereof
09/01/2010EP2222160A2 Haloallylamine inhibitors of ssao/vap-1 and uses therefor
09/01/2010EP1979322B1 Cyclohexyl sulfonamide derivatives having h3 receptor activity
09/01/2010EP1594854B1 Thiazolyl-based compounds useful as kinase inhibitors
09/01/2010EP1379508B1 N-(aryl)-2-arylethenesulfonamides and therapeutic uses thereof
09/01/2010EP1028942B1 Dipeptide nitriles
09/01/2010CN101821238A Compounds which inhibit BETA-SECRETASE activity and methods of use thereof
09/01/2010CN101817811A 1,3-dimethylbutyl carboxanilides for controlling undesirable micro-organisms
09/01/2010CN101817803A Beta-amino acid esters having optical activity and containing benzothiazole groups and synthetic method and application thereof
09/01/2010CN101817802A Preparation of N-substituted phenyl-2, 4-dioxo-5-thiazolidine formamide having insulin-sensitizing effect
09/01/2010CN101817801A Preparation method of new crystal form K of 2-(3-cyano-4-isobutoxy)-4-methyl-5-thiazole formic acid and other crystal forms
09/01/2010CN101817784A Ethylene derivatives and pesticides containing said derivatives
08/2010
08/31/2010US7786165 Antidiabetic agents; obesity; insulin resistance; neurodegenerative diseases; Alzheimer's disease
08/31/2010US7786162 Agents useful for reducing amyloid precursor protein and treating dementia and methods of use thereof
08/31/2010US7786153 Compounds that are useful for improving pharmacokinetics
08/31/2010US7786152 Inhibiting 11 beta-hydroxysteroid dehydrogenase (11 beta-HSD); use of sulfonamide-substituted N-heterocyclics including pyrroles, oxazoles, thiazoles, imidazoles and their fused analogs to treat diabetes, obesity, hypertension, arthritis, asthma, osteoporosis, breast cancer
08/31/2010US7786150 substituted pyrrolidine derivatives, used for the treatment vision defects such as glaucoma or ocular hypertension
08/31/2010US7786145 Cyanoguanidine-based azole compounds useful as malonyl-CoA decarboxylase inhibitors
08/31/2010US7786122 use to treat Alzheimer's Disease; (2R)-2-[N-(4-Chlorobenzenesulfonyl)-N-(4-methoxybenzyl)amino]-4-methylpentanoic acid amide for example
08/31/2010US7786117 used for treating glaucoma, inflammatory bowel disease and alopecia
08/31/2010US7786110 Thiazole and oxazole-substituted arylamides as P2X3 and P2X2/3 antagonists
08/31/2010CA2364493C Nitrate esters and their use for neurological conditions
08/26/2010WO2010094755A1 Carboxamide compounds and their use as calpain inhibitors
08/26/2010WO2010094666A2 Fungicidal n-(phenylcycloalkyl)carboxamide, n-(benzylcycloalkyl)carboxamide and thiocarboxamide derivatives
08/26/2010WO2010094659A1 Amine or amino alcohols as glyt1 inhibitors
08/26/2010WO2010094242A1 Spiropyrrolidine beta-secretase inhibitors for the treatment of alzheimer's disease
08/26/2010WO2010076033A9 Toluidine sulfonamides and their use
08/26/2010WO2010066682A4 Compounds, pharmaceutical composition and methods for use in treating metabolic disorders
08/26/2010US20100216853 Methods and Compositions for Modulating P300/CBP Activity
08/26/2010US20100216849 Biphenylcarboxamides
1 ... 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 ... 337